Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study

Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2000, Pages 514-519

  Pauli Magnus, Christiane ^a,b   Mikus, Gerd ^b   Alscher, Dominik M ^a   Kirschner, Tillmann ^c   Nagel, Wilfried ^d   Gugeler, Nadja ^b   Risler, Teut ^e   Berger, Elke D ^e   Kuhlmann, Ulrich ^a   Mettang, Thomas ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c Dialysis Center Stuttgart   (Germany)

^d Dialysis Center Dürrlewang   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; TREATMENT OUTCOME; UREMIA;

EID: 18244416618     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Balaskas EV, Chu M, Uldall RP, Gupta A, Oreopoulos DG: Pruritus in continuous ambulatory peritoneal dialysis and hemodialysis patients. Perit Dial Int 1[Suppl 2]: 527-532, 1993
2. Mettang T, Fischer FP, Kuhlmann U: Urämischer Pruritus. Dtsch Med Wochenschr 12: 1025-1031, 1996
3. Nielsen T, Andersen KE, Kristiansen J: Pruritus and xerosis in patients with chronic renal failure. Dan Med Bull 27: 269-271, 1980
4. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Kleeman CR: Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. N Engl J Med 279: 697-700, 1968
5. Thomas P, Hollinrake R, Lascelles R: The polyneuropathy of chronic renal failure. Brain 94: 761-780, 1971
6. Gill DS, Fonseca VA, Balliod R, Moorhead JF, Dandona P: Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol 44: 243-245, 1991
7. Bousquet J, Maurice F, Rivory P: Allergy in long-term hemodialysis. II. Allergic and atopic patterns of a population undergoing long-term hemodialysis. J Allergy Clin Immunol 81: 605-610, 1988
8. De Marchi S, Cecchin E, Villalta D, Sepiacci G, Santini G, Bartoli E: Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 326: 969-974, 1992
9. Hiroshige K, Kabashima N, Tagasugi M, Kuroiwa A: Optimal dialysis improves uremic pruritus. Lancet i: 215, 1981
10. Goyal S, Gittlen S, Schulman ES, Burke JF, Besarab A, Francos G: Elevated histamine levels in uremia: Effects of ketotifen in patients with uremic pruritus. Kidney Int 31: 233-237, 1987
11. Andersen LW, Friedberg M, Lokkegaard N: Naloxone in treatment of uremic pruritus: A case history. Clin Nephrol 21: 355-356, 1984
12. Peer G, Kivity S, Agami O: Randomized crossover trial of naltrexone in uremic pruritus. Lancet 348: 1552-1554, 1996
13. Duo LJ: Electrical needle therapy of uremic pruritus. Nephron 47: 179-183, 1979
14. Mettang T, Fritz P, Weber J, Machleidt C, Hübl E, Kuhlmann U: Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD): The role of plasma histamine and skin mast cells. Clin Nephrol 34: 136-141, 1990
15. Thornton JR, Losowsky MS: Opioid peptides and primary biliary cirrhosis. Br Med J 297: 1501-1504, 1988
16. Bergasa NV, Jones EA: The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids. Gastroenterology 108: 1582-1588, 1995
17. Bergasa NV, Ailing DW, Talbot TL: Effects of naloxone infusion in patients with the pruritus of cholestasis: A double-blind randomized controlled trial. Ann Intern Med 123: 161-167, 1995
18. Bergasa NV, Schmitt JM, Talbot TL: Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 27: 679-684, 1998
19. Bergasa NV, Rothman RB, Vergalla J, Xu H, Swain MG, Jones EA: Central muopioid-receptors are down-regulated in a rat model of acute cholestasis. J Hepatol 15: 220-224, 1992
20. Aronin N, Krieger DT: Plasma immuno-reactive β-endorphin is elevated in uremia. Clin Endocrinol 18: 459-464, 1983
21. Trelewicz P, Grzeszczak W, Drabczyk R: Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure. Int Urol Nephrol 26: 117-123, 1994
22. Elias AN, Vaziri ND, Maksy M: Plasma beta-endorphin and beta-lipotropin in patients with end-stage-renal disease effects of hemodialysis. Nephron 43: 173-176, 1986
23. Mettang T, Fischer FP, Dollenbacher U, Kuhlmann U: Uremic pruritus is not related to beta-endorphin serum levels in hemodialysis. Nephrol Dial Transplant 13: 231-232, 1998
24. Cho YL, Liu HN, Huang TP, Tarng DC: Uremic pruritus: Roles of parathyroid hormone and substance P. J Am Acad Dermatol 36: 538-543, 1997